Matt Darin

Curaleaf Reports Q1 2024 Revenue Of $339M, 48% Gross Margin Amid Strategic Global Expansion
Curaleaf's Dual Expansion: Balancing Medical And Recreational Markets While Emphasizing Social Equity
Global Cannabis Strategies Post-German Legalization: Exclusive Insights From Curaleaf, Gold Flora, Verano
Curaleaf's Dual Expansion: Balancing Medical And Recreational Markets While Emphasizing Social Equity
Global Cannabis Strategies Post-German Legalization: Exclusive Insights From Curaleaf, Gold Flora, Verano
How Will Germany's Cannabis Legalization Change The Game?
US At Cannabis Crossroads: VP Harris Urges DEA Action, Where Do Industry Leaders Stand?

Matt Darin Recent News

Cannabis Giant Curaleaf Expands In This European Country Via New Acquisition
Curaleaf International has acquired Can4Med, a pharmaceutical wholesaler specialising in cannabinoid medications, to expand its operations in Poland. The deal will also improve patient access to medical cannabis products across Europe. Poland's National Agricultural Support Center implemented rules last year that increased the THC level permitted in industrial hemp from 0.2% to 0.3%, facilitating a more streamlined permitting process for farmers and buyers. In August 2022, Curaleaf International registered its extract-based medicines in Poland through a partnership with local firm CanPoland. Last year, Poland saw a significant increase in the adoption of medical cannabis, with over 3,000 kg distributed. Curaleaf CEO Matt Darin called the acquisition a "significant step forward" for his company, as Poland's medical cannabis market expands rapidly.
Beat The Winter Blues With Pink Infusions, Moonrocks And Sober Alternatives To Hard Seltzers
Compact Elegance: Pink Stündenglass Kompact Stündenglass introduces the Pink Kompact, a smaller version of its gravity infuser, just in time for Valentine's Day. The Pink Kompact combines the sophisticated design and kinetic motion activation of its predecessor in a more portable format.
DEA's Cannabis Classification: Time To Right A Decades-Old Mistake As Feds Confirm Marijuana's Medical Benefits
Schedule I drugs are defined by the DEA as substances with no “currently accepted medical use and a high potential for abuse.” The list includes heroin, LSD, ecstasy, meth, peyote, and, for the past 24 years, cannabis.
Curaleaf Will Ring Opening Bell At Toronto Stock Exchange To Celebrate Landmark Listing
Curaleaf Holdings, Inc. announced on Tuesday that it has complied with all the conditions listed in the conditional listing approval delivered by the Toronto Stock Exchange in connection with the listing of its subordinate voting shares on the TSX. The cannabis giant said the shares will commence trading on the TSX on Thursday, Dec, 14. under the ticker symbol "CURA." It will celebrate the milestone by ringing the opening bell of the TSX in Toronto on the same day.In connection with the TSX listing, the shares will be delisted from the Canadian Securities Exchange (CSE) at the close of markets on Wednesday, Dec. 13.
Curaleaf Holdings Reports Q3 2023 Cannabis Revenue Of $333M, 23% EBITDA Margin
Curaleaf Holdings, Inc.,  (OTC: CURLF) a prominent global cannabis consumer product provider disclosed its financial results late Thursday for Q3 2023.
New York's $83M In Legal Weed Sales, More Shops & Licenses: Is The Rollout Stabilizing?
Despite licensing chaos, lawsuits and a booming illicit weed market, New York's two dozen legal weed shops managed to pull in $83 million year-to-date, according to the state’s cannabis regulator. 
Weed-Infused Beverage By Curaleaf Hits The Shelves, Here's Where You Can Find It
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) announced on Tuesday the launch of Zero Proof, a new brand of THC drinkables in fast-acting, sessionable and easy-to-use formats.
Medical Marijuana Giants Lambaste NY Gov. Hochul For Weed Rollout Mess, Seek Licenses To Sell Recreational Weed
Four major medical marijuana retailers in New York sent a letter to Gov.
Curaleaf's Boris Jordan: No Capital Raises Planned, Company Has $50M In Revolving Credit
Price pressure has been a common theme in this past week's round of cannabis earnings.
Curaleaf's Q2 2023 Revenue Up 1% Sequentially To $339M, 4% Increase YoY & Adjusted EBITDA $70M
Curaleaf Holdings (OTCQX: CURLF reported its financial and operating results Wednesday afternoon for the second quarter ended June 30, 2023. 
Cannabis Giant Curaleaf Trims Workforce in New Jersey Amid Market Glut
Curaleaf Holdings Inc (OTC: CURLF), a cannabis multistate operator (MSO), recently laid off 49 workers at its Winslow, New Jersey production facility.
New Mobile App For Cannabis Users To Order Favorite Products, Read About Discounts And More
Curaleaf Holdings, Inc. (OTCQX: CURLF) (CSE:CURA) launched its first standalone mobile app, now available in all 19 states where the company operates.
Curaleaf Q1 Revenue Grows 14%, Optimizing U.S. Assets & Heading To Europe Says Boss Boris Jordan
Curaleaf Holdings Inc. (CSE: CURA) (OTC: CURLF) released its financial results for the first quarter ended March 31, 2023.
Senate Finally Addresses Banking Reform For Billion-Dollar Cannabis Industry, What Took So Long?
Anxiety is running high in the cannabis industry as the Senate Banking Committee gets ready to discuss the Secure and Fair Enforcement (SAFE) Banking Act, which seeks to normalize relations between state-licensed cannabis businesses and financial institutions. 
New Jersey Gov Murphy Signs Law Relieving Cannabis Companies Of Punitive IRS Tax Code, Who's Next?
New Jersey Gov. Phil Murphy did the cannabis industry in his state a huge favor when he signed a law decoupling marijuana businesses from federal IRS Code Section 280E, the bane of the industry’s collective existence. 
NJ CRC Board Reverses Itself And Fully Approves Curaleaf's Adult Use License Renewals After Legal Challenge
Curaleaf Holdings, Inc. (OTCQX: CURLF) (CSE:CURA) announced that on April 17th, the board of the New Jersey Cannabis Regulatory (CRC) reversed itself and voted to approve Curaleaf's adult use cannabis licenses.
Curaleaf Expanding Its Footprint In Florida With 59th Dispensary And Plans For More To Come
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) announced Friday that it is opening Curaleaf Boca Raton Glades, the company's 59th dispensary in Florida and 151st nationwide. Located at 7875 Glades Rd, Boca Raton, FL 33434, the new shop is t
Curaleaf Acquires Deseret Wellness
Curaleaf Holdings, Inc. (CSE:CURA) (OTCQX: CURLF) announced the completion of its acquisition of Deseret Wellness. With the close of the transaction, Curaleaf's retail footprint has increased to four dispensaries in Utah and 150 nationwide.
Twitter, Uber, Investors, Cannabis Companies And Advocates Converging Soon In Miami
The Benzinga Cannabis Capital Conference, renowned as the world’s largest and most successful cannabis investing and finance event is being held at the iconic Fountainbleu Hotel in Miami Beach on April 11-12, 2023
Curaleaf To Buy Three Dispensaries In An Important Emerging Market
Curaleaf Holdings, Inc. (OTCQX: CURLF) (CSE: CURA) has entered into a definitive agreement to acquire Deseret Wellness, a cannabis retail operator in Utah, in a cash and stock transaction valued at approximately $20 million.
Maximize Your Returns: Get To Know The Top Performing Cannabis Stocks Of The Last 12 Months
The past 12 months have been a wild ride for both investors and cannabis shareholders, as evidenced by big rallies as well as steep declines.
Curaleaf Is The First Dispensary To Begin Adult-Use Cannabis Sales In Hartford, Connecticut
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) will commence adult-use sales at its Hartford, Connecticut location beginning March 1 at 9:00 am EST.
Shop Legal Weed Now: New Stores Open In Two States And Canada
Cresco To Hit 60 Store Milestone, Announces New Openings